Clinical Trial Update: Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating 0.2% chlorhexidine digluconate mouthwash to prevent alveolar osteitis after third molar extraction; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alveolar Osteitis

Drugs mentioned

• Chlorhexidine digluconate mouthwash 0.2% (Chlorhexidine digluconate mouthwash)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Alveolar Osteitis | Phase 4 | Status: COMPLETED